Today: 22 March 2026
Browse Category

NASDAQ:AMIX 17 November 2025

Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

Autonomix Medical reported 20–30-point gains in quality-of-life scores at three months in a subgroup analysis from its PoC 1 study for severe pancreatic cancer pain. Even Stage 4 patients saw durable symptom and function improvements after nerve ablation. AMIX shares nearly doubled intraday on heavy volume, ranking among Nasdaq’s top gainers. The company remains pre-revenue and highly volatile.

Stock Market Today

  • VTI ETF: Comprehensive Guide for Australian Investors on Vanguard Total Stock Market ETF
    March 22, 2026, 9:02 AM EDT. The Vanguard Total Stock Market ETF (VTI) tracks the CRSP US Total Market Index, covering large-, mid-, and small-cap U.S. shares, offering broad U.S. equity exposure. Australian investors can access VTI directly via the NYSE or through the ASX cross-listing VTS. VTI is U.S.-domiciled and exposes investors to unhedged USD currency risk, necessitating attention to tax, administrative, and estate-planning implications. VTS provides a straightforward ASX alternative with equivalent underlying assets. For those seeking S&P 500 exposure only, the Australian-domiciled IVV ETF is preferable. VTI's management fee is low at 0.03% annually with a fund size exceeding US$570 billion, holding over 3,500 stocks. Australians should evaluate listing, domicile, ASX equivalents, and currency hedging before investing.
Go toTop